WT1 expression as an independent marker of poor prognosis in colorectal cancers

Cancer Biomarkers

Volumn 8, Issue 1, 2010, Pages 35-42

  Bejrananda, Tanan ^a   Phukaoloun, Monlika ^a   Boonpipattanapong, Teeranut ^a   Wanitsuwan, Worawit ^a   Kanngern, Samornmas ^a   Sangthong, Rassamee ^a   Sangkhathat, Surasak ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

WT1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 80052597971     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/DMA-2011-0822     Document Type: Article

References (30)

1. A. Jemal, M.M. Center, C. DeSantis and E.M. Ward, Global patterns of cancer incidence and mortality rates and trends, Cancer Epidemiol Biomarkers Prev 19 (2010), 1893-1907.
2. T. Boonpipattanapong and S. Chewatanakornkul, Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas, J Clin Gastroen-terol 40 (2006), 592-595. (Pubitemid 44259763)
3. W. Wanitsuwan, S. Kanngurn, T. Boonpipattanapong, R. Sangthong and S. Sangkhathat, Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers, World J Gastroenterol 14 (2008), 6052-6059.
4. S. Anwar, I.M. Frayling, N.A. Scott and G.L. Carlson, Systematic review of genetic influences on the prognosis of colorectal cancer, Br J Surg 91 (2004), 1275-1291. (Pubitemid 39331451)
5. L. Belov, J. Zhou and R.I. Christopherson, Cell surface markers in colorectal cancer prognosis, Int J Mol Sci 12 (2011), 78-113.
6. P. Hohenstein and N.D. Hastie, The many facets of the Wilms' tumour gene, WT1, Hum Mol Genet 15 Spec No 2 (2006), R196-R201. (Pubitemid 44446794)
7. H. Scholz and K.M. Kirschner, A role for the Wilms' tumor protein WT1 in organ development, Physiology(Bethesda) 20 (2005), 54-59. (Pubitemid 40363371)
8. Y. Oji, S. Miyoshi, H. Maeda, S. Hayashi, H. Tamaki, S. Nakatsuka et al., Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers, Int J Cancer 100 (2002), 297-303. (Pubitemid 34728987)
9. Y. Oji, H. Yamamoto, M. Nomura, Y. Nakano, A. Ikeba, S. Nakatsuka et al., Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma, Cancer Sci 94 (2003), 712-717. (Pubitemid 37160929)
10. A.B. Domfeh, A.L. Carley, J.M. Striebel, R.G. Karabakht-sian, A.V. Florea, K. McManus et al., WT1 immunoreactivity in breast carcinoma: selective expression in pure and mixed mucinous subtypes, Mod Pathol 21 (2008), 1217-1223.
11. S. Sangkhathat, S. Kanngurn, W. Chaiyapan, P. Graidist and W. Maneechay, Wilms' tumor 1 gene (WT1) is overexpressed and provides an oncogenic function in pediatric nephrob-lastomas harboring the wild-type WT1, Oncology Letters 1 (2010), 615-619.
12. S.Y. Hu, W.Y. Gu, Z.X. Chen, X.L. Wang, J.N. Cen, H.L. He et al., The significance of detecting WT1 expression in childhood acute leukemias, Pediatr Hematol Oncol 27 (2010), 581-591.
13. Y. Miyoshi, A. Ando, C. Egawa, T. Taguchi, Y. Tamaki, H. Tamaki et al., High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients, Clin Cancer Res 8 (2002), 1167-1171. (Pubitemid 34517654)
14. E.V. Hogdall, L. Christensen, S.K. Kiaer, J. Blaakaer, I.J. Christensen, S. Gayther et al., Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study, Gynecol Oncol 106 (2007), 318-324. (Pubitemid 47096654)
15. M.A. Cheever, J.P. Allison, A.S. Ferris, O.J. Finn, B.M. Hastings, T.T. Hecht et al., The prioritization of cancerantigens: a national cancer institute pilot project for the acceleration of translational research, Clin Cancer Res 15 (2009), 5323-5337.
16. Y. Oka and H. Sugiyama, WT1 peptide vaccine, one of the most promising cancer vaccines: its present status and the future prospects, Immunotherapy 2 (2010), 591-594.
17. Y. Oji, H. Ogawa, H. Tamaki, Y. Oka, A. Tsuboi, E.H. Kim et al., Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90 (1999), 194-204. (Pubitemid 29112320)
18. S. Nakatsuka, Y. Oji, T. Horiuchi, T. Kanda, M. Kitagawa, T. Takeuchi et al., Immunohistochemical detection of WT1 protein in a variety of cancer cells, Mod Pathol 19 (2006), 804-814. (Pubitemid 43780450)
19. R. Navakanit, P. Graidist, W. Leeanansaksiri and C. Dech-sukum, Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene, J Med Assoc Thai 90 (2007), 2416-2421. (Pubitemid 350256447)
20. W. Glienke, L. Maute, J. Wicht and L. Bergmann, Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells, Eur J Cancer 45 (2009), 874-880.
21. M. Kletzel, M. Olzewski, W. Huang and P.M. Chou, Utility of WT1 as a reliable tool for the detection of minimal residual disease in children with leukemia, Pediatr Dev Pathol 5 (2002), 269-275. (Pubitemid 34712241)
22. M.O. Hiltunen, J. Koistinaho, L. Alhonen, S. Myohanen, S. Marin, V.M. kosma et al., Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer, Br J Cancer 76 (1997), 1124-1130. (Pubitemid 27448006)
23. H.D. Menssen, E. Bertelmann, S. Bartelt, R.A. Schmidt, G. Pecher, K. Schramm et al., Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens, J Cancer Res Clin Oncol 126 (2000), 226-232. (Pubitemid 30183026)
24. R. Koesters, M. Linnebacher, J.F. Coy, A. Germann, Y. Schwitalle, P. Findeisen et al., WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells. Int J Cancer 109 (2004), 385-392. (Pubitemid 38252767)
25. H. Hwang, L. Quenneville, H. Yaziji and A.M. Gown, Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin, Appl Immunohistochem Mol Morphol 12 (2004), 122-126. (Pubitemid 38788760)
26. N.G. Ordonez, Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma, Am J Surg Pathol 24 (2000), 598-606. (Pubitemid 30180755)
27. M. Niksic, J. Slight, J.R. Sanford, J.F. Caceres and N.D. Hastie, The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes, Hum Mol Genet 13 (2004), 463-471. (Pubitemid 38239797)
28. E.R. Fearon, B. Vogelstein, A genetic model for colorectal tumorigenesis, Cell 61 (1990), 759-767.
29. K. Kitisin and L. Mishra, Molecular biology of colorectal cancer: new targets, Semin Oncol 33(6 Suppl 11) (2006), S14-S23.
30. S. Vicent, R. Chen, L.C. Sayles, C. Lin, R.G. Walker, A.K. Gillespie et al., Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models, J Clin Invest 120 (2010), 3940-3952.